VANCOUVER, BC, June 24, 2024 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, announces the resignation of Donna Wong as a director of the Company effective Monday, June 24, 2024.
On behalf of the members of the Board and the management team of Numinus, I would like to thank Donna for her valued contributions and commitment to our progress,” said Payton Nyquvest, Founder, Chair, and CEO of Numinus. “We wish Donna all the best in her future endeavours.
Numinus Wellness Inc. (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, X/Twitter, and Instagram.